Artelo Biosciences Warrants

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ARTLW and buy or sell other stocks, options, and ETFs commission-free!

About ARTLW

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. 

CEO
Gregory D. Gorgas, MBA
CEOGregory D. Gorgas, MBA
Employees
—
Employees—
Headquarters
Solana Beach, California
HeadquartersSolana Beach, California
Founded
2011
Founded2011
Employees
—
Employees—

ARTLW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
1.67K
Average volume1.67K
High today
$0.0116
High today$0.0116
Low today
$0.0116
Low today$0.0116
Open price
$0.0116
Open price$0.0116
Volume
452.00
Volume452.00
52 Week high
$0.21
52 Week high$0.21
52 Week low
$0.005
52 Week low$0.005
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.